Cookies management by TermsFeed Cookie Consent
Recent News

Press Releases

06-04-2021 12:53

19,378 appointments to be made available for the vaccination of persons aged 61 and over

 

  • By 5 April, 165,116 vaccinations were administered (117,615 with the first dose and 47,501 with the 2nd dose of the vaccine)
  • 19,378 appointments will be made available for people aged 61 and over
  • At least 81.65% of people aged 80 years and over and 76.34% of people aged 70-79 years have been vaccinated with the 1st dose.

People aged 61 years and over will be able to arrange appointments for vaccination against COVID-19. The Vaccination Portal will be available for this age group from tomorrow, April 7, at 8 a.m., until Thursday, April 8, at 7 p.m. Specifically, 19,378 appointments will be available at all Vaccination Centres in all districts.

The National Vaccination Plan proceeds on the basis of the planning and focuses on both the vaccination of the general population based on age criteria and on the priority vaccination of individuals belonging to the vulnerable groups of the population. By 5 April 165.116 vaccinations have been administered, of which 117.615 concern the 1st doseof the vaccine and 47.501 concern both doses.7.577 people belonging to vulnerable groups received the 1st dose of the vaccine, while 548 home vaccinations were administered to bed-ridden people.

In relation to vaccination coverage, 81.65% of people aged 80 and over have been vaccinated with at least the 1st dose, while 76.34% of people in the 70-79 age group have received at least the 1st dose of the vaccine. It is recalled that older people than the age group which has priority in each opening of the Vaccination Portal also have access and can schedule appointments. 

According to the information on the quantities of the three authorised vaccines estimated to be dispatched in the next few days, it is expected that the vaccination of vulnerable groups, with at least the 1st dose, will be completed in April and that the vaccination coverage will proceed based on age criteria with the aim of administering by the beginning of May at least the 1st dose of the vaccine to people aged 45 or over.

(MG/MPO)